Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Equity Incentive Plan

v3.24.1.1.u2
Note 7 - Equity Incentive Plan
3 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

Note 7 — Equity Incentive Plan

 

In May 2013, the Company adopted the 2013 Equity Incentive Plan (as amended and restated, the “Plan”) and reserved shares of common stock for issuance under the Plan, which was last amended in June 2023. The Plan is administered by the Compensation Committee of the Company’s Board of Directors. At March 31, 2024, 453,839 shares of common stock were available for issuance under the Plan.

 

A summary of the Company’s stock option activity and related information is as follows:

 

                   

Weighted

 
           

Weighted

   

Average

 
           

Average

   

Remaining

 
   

Stock

   

Exercise

   

Life

 
   

Options

   

Price

   

(in years)

 

Outstanding at December 31, 2023

    525,948     $ 7.69       6.6  

Exercised

    (8,334 )   $ 10.41          

Outstanding at March 31, 2024

    517,614     $ 7.65       5.4  

Exercisable at March 31, 2024

    479,285     $ 7.34       5.2  

 

 

A summary of the Company’s restricted stock unit (RSU) and performance stock unit (PSU) activity is as follows:

 

   

RSUs

   

PSUs

 

Outstanding at December 31, 2023

    171,530       114,000  

Granted

    50,710        

Vested

    (9,679 )      

Outstanding at March 31, 2022

    212,561       114,000  

 

During the three months ended March 31, 2024, the Company granted 38,710 RSUs to Board members and 12,000 RSUs to employees under the Plan. The estimated fair value of these equity grants was $397,803, $82,362 of which was recognized during the three months ended March 31, 2024.

 

At March 31, 2024, there was $1,885,023 of unrecognized compensation cost related to non-vested equity awards granted under the Plan. That cost is expected to be recognized over a weighted average period of 0.9 years.